Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Daniels is active.

Publication


Featured researches published by Mark Daniels.


Journal of Clinical Investigation | 2004

Novel APC-like properties of human NK cells directly regulate T cell activation

Jacob Hanna; Tsufit Gonen-Gross; Jonathan Fitchett; Tony Rowe; Mark Daniels; Tal I. Arnon; Roi Gazit; Aviva Joseph; Karoline W. Schjetne; Alexander Steinle; Angel Porgador; Dror Mevorach; Debra Goldman-Wohl; Simcha Yagel; Michael Labarre; Jane H. Buckner; Ofer Mandelboim

Initiation of the adaptive immune response is dependent on the priming of naive T cells by APCs. Proteomic analysis of unactivated and activated human NK cell membrane-enriched fractions demonstrated that activated NK cells can efficiently stimulate T cells, since they upregulate MHC class II molecules and multiple ligands for TCR costimulatory molecules. Furthermore, by manipulating antigen administration, we show that NK cells possess multiple independent unique pathways for antigen uptake. These results highlight NK cell-mediated cytotoxicity and specific ligand recognition by cell surface-activating receptors on NK cells as unique mechanisms for antigen capturing and presentation. In addition, we analyzed the T cell-activating potential of human NK cells derived from different clinical conditions, such as inflamed tonsils and noninfected and CMV-infected uterine decidual samples, and from transporter-associated processing antigen 2-deficient patients. This in vivo analysis revealed that proinflammatory, but not immune-suppressive, microenvironmental requirements can selectively dictate upregulation of T cell-activating molecules on NK cells. Taken together, these observations offer new and unexpected insights into the direct interactions between NK and T cells and suggest novel APC-like activating functions for human NK cells.


Journal of Clinical Investigation | 2003

A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma

Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Hadas Shiran; Xiangjun Zhou; Huifan Yan; Hongqi Lu; Zhilan Zeng; Qingxue Wang; Tao Li; Andrew R. Hoffman

IGF-II is a mitogenic peptide that has been implicated in hepatocellular oncogenesis. Since the silencing of gene expression is frequently associated with cytosine methylation at cytosine-guanine (CpG) dinucleotides, we designed a methylated oligonucleotide (MON1) complementary to a region encompassing IGF2 promoter P4 in an attempt to induce DNA methylation at that locus and diminish IGF2 mRNA levels. MON1 specifically inhibited IGF2 mRNA accumulation in vitro, whereas an oligonucleotide (ON1) with the same sequence but with nonmethylated cytosines had no effect on IGF2 mRNA abundance. MON1 treatment led to the specific induction of de novo DNA methylation in the region of IGF2 promoter hP4. Cells from a human hepatocellular carcinoma (HCC) cell line, Hep 3B, were implanted into the livers of nude mice, resulting in the growth of large tumors. Animals treated with MON1 had markedly prolonged survival as compared with those animals treated with saline or a truncated methylated oligonucleotide that did not alter IGF2 mRNA levels in vitro. This study demonstrates that a methylated sense oligonucleotide can be used to induce epigenetic changes in the IGF2 gene and that inhibition of IGF2 mRNA accumulation may lead to enhanced survival in a model of HCC.


Transplantation | 2003

Bone mineral density in pediatric transplant recipients1

Mark Daniels; Darrell M. Wilson; Helen G. Paguntalan; Andrew R. Hoffman; Laura K. Bachrach

Background. Reduced bone mass and fragility fractures are known complications after transplantation in adults. Far less is known about the skeletal effects of transplantation in children and adolescents. Methods. This cross-sectional study examined the skeletal status of children (ages 9–18 years) who were at least 1 year post-cardiac (n=13), post-renal (n=8), or post-bone marrow (BMT; n=15) transplantation. Bone mass at total hip, femoral neck, spine (L2-4), and whole body (WB) was determined by dual energy x-ray absorptiometry and compared with age, sex, and ethnic-specific reference data. Standard deviations (z-scores) were calculated for both areal bone mineral density (BMD) and estimated volumetric bone density (bone mineral apparent density [BMAD]). Results. Cardiac transplant patients had significantly lower BMD z-scores compared with the reference population at all skeletal sites. BMT recipients had significantly reduced BMD z-scores at total hip, spine, and WB. Kidney transplant patients had a significantly reduced WB BMD z-score only. Spine BMAD z-scores remained significantly reduced in cardiac and BMT subjects. Three of 36 patients had radiographic evidence of spinal fracture after transplantation. No correlation between steroid dosage and any measure of bone mass was observed. Conclusions. Cardiac and BMT recipients had reduced BMD at multiple skeletal sites, and renal transplant recipients had reduced WB BMD for age. Deficits in spine bone density persisted after correcting for small bone size using BMAD. Low bone density and the occurrence of vertebral fractures indicate that cardiac, renal, and bone marrow transplantation in children is associated with reduced bone health.


Archive | 2011

Sample Preparation of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue for Proteomic Analyses

Diem Tran; Mark Daniels; Ben Colson; Dikran Aivazian; Antonio Boccia; Ingrid Joseph; Steffan Ho; Steve French; Alex Buko; Jing Wei

A sample preparation procedure has been developed to prepare Formalin-Fixed Paraffin-Embedded (FFPE) tissues for proteomic profiling. Protocols have been established for processing FFPE sections on slides, including deparaffinization, rehydration, protein extraction, and enzymatic digestion, all using in-house developed and optimized buffers and techniques. These methods are practical and allow for parallel sample processing. The efficiency of protein extraction from FFPE tissue is comparable to the results from fresh or frozen tissue. The prepared samples can be directly coupled to a wide range of proteomic technologies, including isobaric labeling and on-line multidimensional chromatography. Comprehensive proteomic profiling of prepared FFPE tissue was performed using a fully automated tandem multidimensional liquid chromatography (LC) system coupled with on-line electrospray ionization (ESI) tandem mass spectrometry (MS): LC/LC-MS/MS. Routinely around 4,000 unique proteins of high confidence could be identified from 100 μg of extracted protein. The method presented here will be valuable for others who plan to analyze FFPE tissues.


Clinical Cancer Research | 2003

A Novel Orthotopic Tumor Model to Study Growth Factors and Oncogenes in Hepatocarcinogenesis

Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Huifan Yien; Hongqi Lu; Hadas Sharan; Xiangjun Zhou; Zhilan Zeng; Tao Li; Youwen Yang; Andrew R. Hoffman


Molecular Immunology | 2005

Proteomic analysis of human natural killer cells: insights on new potential NK immune functions.

Jacob Hanna; Jonathan Fitchett; Tony Rowe; Mark Daniels; Melissa Heller; Tsufit Gonen-Gross; Efrat Manaster; Samuel Y. Cho; Michael Labarre; Ofer Mandelboim


Archive | 2005

Membrane Associated Molecules

Pamela Bechtel; Mark Daniels; Karen Mclachlan; Yufeng Zhai; Benjamin L. Colson; Nicole W. O'brien


Archive | 2006

Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors

Jonathon Fitchett; Mark Daniels; Michael Labarre; Karen Mclachlan; Tony Rowe; Nicole W. O'brien; Samuel Y. Cho; Melissa Heller


Archive | 2003

Genes overexpressed by ovarian cancer and their use in developing novel therapeutics

Hariharan Kandasamy; Mark Daniels; Karen Mclachlan


Archive | 2002

Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies

Karen Mclachlan; Mitchell Reff; Mark Daniels

Collaboration


Dive into the Mark Daniels's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacob Hanna

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Ofer Mandelboim

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Tsufit Gonen-Gross

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge